These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11068762)

  • 1. Analysis of T-cell response using altered peptide ligands.
    Boisgérault F; Anosova N; Fedoseyeva EV; Tam RC; Benichou G
    Methods Mol Biol; 2001; 156():211-8. PubMed ID: 11068762
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and function of MHC: molecular mechanisms for antigen processing and antigen presentation to T cells].
    Nishimura Y
    Tanpakushitsu Kakusan Koso; 2000 May; 45(7):1205-18. PubMed ID: 10806862
    [No Abstract]   [Full Text] [Related]  

  • 3. Enrichment of antigen-specific T lymphocytes by panning on immobilized MHC-peptide complexes.
    Bousso P; Michel F; Pardigon N; Bercovici N; Liblau R; Kourilsky P; Abastado JP
    Immunol Lett; 1997 Nov; 59(2):85-91. PubMed ID: 9373216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.
    Evavold BD; Sloan-Lancaster J; Allen PM
    Immunol Today; 1993 Dec; 14(12):602-9. PubMed ID: 8305133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological adjuvants efficiently induce antigen-specific T cell responses in old mice: implications for vaccine adjuvant development in aged individuals.
    Ebhardt MB; Shive CL; Guardia R; Gapin L; Boehm BO; Forsthuber TG
    Cell Immunol; 2002 Jan; 215(1):87-97. PubMed ID: 12142040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lighting up TCR takes advantage of serial triggering.
    Chakraborty AK
    Nat Immunol; 2002 Oct; 3(10):895-6. PubMed ID: 12352963
    [No Abstract]   [Full Text] [Related]  

  • 7. Tweaking T cells with altered antigens.
    McCarthy M
    Lancet; 1996 Feb; 347(8999):460. PubMed ID: 8618493
    [No Abstract]   [Full Text] [Related]  

  • 8. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
    Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
    Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes.
    Hommel M; Kyewski B
    J Exp Med; 2003 Feb; 197(3):269-80. PubMed ID: 12566411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-presentation properties of plasmacytoid dendritic cells.
    Villadangos JA; Young L
    Immunity; 2008 Sep; 29(3):352-61. PubMed ID: 18799143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo.
    DiMolfetto L; Neal HA; Wu A; Reilly C; Lo D
    Cell Immunol; 1998 Jan; 183(1):70-9. PubMed ID: 9578721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology. Restless T cells sniff and go.
    Mustelin T
    Science; 2006 Sep; 313(5795):1902-3. PubMed ID: 17008518
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of CTL reactivity in the spleen and draining lymph nodes after immunization with peptides pulsed on dendritic cells or mixed with Freund's incomplete adjuvant.
    Wang MJ; Nissen MH; Buus S; Röpke C; Claësson MH
    Immunol Lett; 2003 Nov; 90(1):13-8. PubMed ID: 14611902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic differentiation model for the action of altered TCR ligands.
    Lord GM; Lechler RI; George AJ
    Immunol Today; 1999 Jan; 20(1):33-9. PubMed ID: 10081228
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimation of maximal affinities between T-cell receptors and MHC/peptide complexes.
    Salzmann M; Bachmann MF
    Mol Immunol; 1998 Feb; 35(2):65-71. PubMed ID: 9683252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes.
    Skokos D; Shakhar G; Varma R; Waite JC; Cameron TO; Lindquist RL; Schwickert T; Nussenzweig MC; Dustin ML
    Nat Immunol; 2007 Aug; 8(8):835-44. PubMed ID: 17632517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical applications of antigen-specific detection of T lymphocytes].
    Kalergis AM; Fierro A; Figueroa C; González P; Tobar J
    Rev Med Chil; 2004 Mar; 132(3):371-80. PubMed ID: 15376576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective elimination of antigen-specific line T cells and ex vivo antigen-primed lymph node cells by antigen-targeted drug-labeled antigen-presenting cell membranes.
    Chang NH; Boggs JM
    Cell Immunol; 1997 Mar; 176(2):135-45. PubMed ID: 9073386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant-induced selective recruitment of specifically reactive lymphocytes: a probable mechanism of adjuvant action.
    Emeson EE
    J Immunol; 1980 May; 124(5):2222-30. PubMed ID: 6245138
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
    Welch AM; Swierkosz JE; Swanborg RH
    J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.